Objective: To evaluate the long-term effectiveness and tolerability of adalimumab in the treatment of psoriatic arthritis (PsA). Methods: Patients with PsA who completed a 24-week, double-blind study ...

HB-0036 is under clinical development by Huabo Biopharm (Shanghai) and currently in Phase II for Melanoma. According to GlobalData, Phase II drugs for Melanoma have a 27% phase transition success rate ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Chronic inflammation often flies under the radar, subtly damaging the body over time. Unlike acute inflammation, which helps the body heal from injuries or infections, chronic inflammation lingers, ...

Whether it's a shooting pain or a dull ache, neck pain is extremely common: about 71 percent of Canadians will experience ...